ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 47 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,659,000 | +4.4% | 105,000 | 0.0% | 0.03% | +14.8% |
| Q2 2023 | $1,589,700 | +4.4% | 105,000 | 0.0% | 0.03% | -15.6% |
| Q1 2023 | $1,522,500 | +7.2% | 105,000 | 0.0% | 0.03% | -5.9% |
| Q4 2022 | $1,419,600 | -14.2% | 105,000 | 0.0% | 0.03% | -12.8% |
| Q3 2022 | $1,655,000 | +29.4% | 105,000 | 0.0% | 0.04% | +14.7% |
| Q2 2022 | $1,279,000 | +29.7% | 105,000 | 0.0% | 0.03% | +36.0% |
| Q1 2022 | $986,000 | -45.2% | 105,000 | 0.0% | 0.02% | -30.6% |
| Q4 2021 | $1,798,000 | – | 105,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $64,173,868 | 26.74% |
| 5AM Venture Management, LLC | 4,408,379 | $63,921,496 | 16.35% |
| 72 Investment Holdings, LLC | 509,023 | $7,380,833 | 3.50% |
| StepStone Group LP | 761,277 | $11,038,517 | 2.05% |
| TCG Crossover Management, LLC | 584,955 | $8,481,848 | 1.65% |
| Redmile Group, LLC | 1,831,608 | $26,558,316 | 1.15% |
| Nan Fung Group Holdings Ltd | 73,582 | $1,066,939 | 0.73% |
| Baker Brothers Advisors | 4,865,819 | $70,554,376 | 0.38% |
| CHI Advisors LLC | 56,374 | $817,423 | 0.22% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,522,500 | 0.03% |